M. Minami et al., THE HYPOTENSIVE EFFECTS OF INTRACEREBROVENTRICULARLY ADMINISTERED DOPAMINE-3-O-SULFATE IN ANESTHETIZED RATS, Biogenic amines, 11(6), 1995, pp. 487-504
We previously reported that dopamine (DA)-4-O-sulfate increased contra
ctile force in a dose dependent manner but that synthesized DA-3-O-sul
fate had no any significant effects on rabbit papillary muscle. In thi
s study, we have looked into the vascular effect of the DA-sulfates. D
A-4-O-sulfate produced a dose-dependent vasoconstriction on isolated r
at aorta and this vasoconstriction was significantly inhibited by praz
osin, domperidone and verapamil. The intravenous administration of DA-
4-O-sulfate increased rat blood pressure in a dose-dependent manner. T
his presser effect was also significantly inhibited by bunazosin, yohi
mbine and verapamil. Intracerebraoventricular (i.c.v.) injection of DA
-4-O-sulfate caused an increase in blood pressure, which was followed
by a decrease. DA-3-O-sulfate (i.c.v) produced a significant decrease
in the blood pressure of rats. The responses to DA-CO-sulfate and DA-3
-O-sulfate were significantly inhibited by clonidine. This is the firs
t report that DA-3-O-sulfate has a centrally active depressor effect.
These results suggest that central DA-sulfates regulate blood pressure
in addition to the intermediating in the catecholamine metabolism.